These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8599429)

  • 1. Interleukin (IL)-1 alpha- and -1 beta-, IL-6-, and tumor necrosis factor-alpha-like immunoreactivities in human common and dysplastic nevocellular nevi and malignant melanoma.
    Ahmed AA; Nordlind K; Hedblad M; Lagerholm B; Schultzberg M; Lidén S
    Am J Dermatopathol; 1995 Jun; 17(3):222-9. PubMed ID: 8599429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of cytokines in nevi.
    Fleming MG; Howe SF; Candel AG
    Am J Dermatopathol; 1992 Dec; 14(6):496-503. PubMed ID: 1471747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral dysplastic nevi associated with malignant melanoma.
    Misago N; Takahashi M; Kohda H
    J Dermatol; 1991 Nov; 18(11):649-53. PubMed ID: 1800531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma and nevocellular nevi. Histogenesis and relationships. Fluorescence-microscopic and catamnestic photographic studies.
    Paul E
    Norm Pathol Anat (Stuttg); 1984; 48():1-112. PubMed ID: 6701085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unna's and Miescher's nevi: two different types of intradermal nevus: hypothesis concerning their histogenesis.
    Yus ES; del Cerro M; Simón RS; Herrera M; Rueda M
    Am J Dermatopathol; 2007 Apr; 29(2):141-51. PubMed ID: 17414435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
    Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
    J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolytic hyperkeratosis in nevi. A possible marker for atypia.
    Williams BT; Barr RJ
    Am J Dermatopathol; 1996 Apr; 18(2):156-8. PubMed ID: 8739990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of fluorescence in malignant melanoma and nevocellular nevus using a fluorescence microscope and formalin-fixed specimens.
    Shukuwa T; Nonaka S; Yoshida H
    J Dermatol; 1990 Sep; 17(9):538-44. PubMed ID: 2277143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
    Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
    J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Developing from an Intradermal Nevus: Report on Two Patients.
    Ledić Drvar D; Radoš J; Manola I; Mataić A; Dotlić S; Krušlin B
    Acta Dermatovenerol Croat; 2023 Aug; 31(1):40-42. PubMed ID: 37843090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin-binding protein expression in benign and malignant melanocytic proliferations.
    Bouffard D; Duncan LM; Howard CA; Mihm MC; Byers HR
    Hum Pathol; 1994 Jul; 25(7):709-14. PubMed ID: 8026830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma.
    Clark WH; Tucker MA
    Hum Pathol; 1998 Jan; 29(1):8-14. PubMed ID: 9445128
    [No Abstract]   [Full Text] [Related]  

  • 19. A distinctive melanocytic lesion associated with melanoma-prone dysplastic naevus syndrome: the hybrid naevus.
    Schubert C; Parwaresch R; Rudolph P
    Virchows Arch; 2001 Feb; 438(2):166-72. PubMed ID: 11253119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
    Smoller BR; McNutt NS; Hsu A
    Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.